Looking at the universe of stocks we cover at Dividend Channel, on 5/8/14, Buckeye Partners, L.P. (BPL - Get Report) will trade ex-dividend, for its quarterly dividend of $1.10, payable on 5/19/14. As a percentage of BPL's recent stock price of $78.54, this dividend works out to approximately 1.40%, so look for shares of Buckeye Partners, L.P. to trade 1.40% lower — all else being equal — when BPL shares open for trading on 5/8/14.Below is a dividend history chart for BPL, showing historical dividends prior to the most recent $1.10 declared by Buckeye Partners, L.P.: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from BPL is likely to continue, and whether the current estimated yield of 5.60% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of BPL shares, versus its 200 day moving average: Looking at the chart above, BPL's low point in its 52 week range is $62.00 per share, with $79.37 as the 52 week high point — that compares with a last trade of $78.54. According to the ETF Finder at ETF Channel, BPL makes up 5.35% of the MLP ETF ( MLPA) which is trading higher by about 0.1% on the day Wednesday. In Wednesday trading, Buckeye Partners, L.P. shares are currently down about 0.2% on the day.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Home Depot, Kohl's, Nike, General Motors and Huawei - 5 Things You Must Know
U.S. stock futures rise after the U.S. eases restrictions on China's Huawei; Nike leads a group of athletic apparel and shoe companies in an effort to urge Donald Trump to reconsider placing tariffs on footwear; Home Depot, Kohl's and Nordstrom report earnings.
Merck's Keytruda Fails to Meet Goal in Breast Cancer Trial
Merck says one of its key cancer-fighting drugs, Keytruda, failed to meet its stand-alone goal of treating an aggressive type of breast cancer.
Dow Futures Gain, Global Tech Rebounds, as US Eases Restrictions on Huawei
Global stocks snapped back Tuesday, reversing much of the previous day's decline, following a move by the Commerce Department to ease restrictions on China's Huawei Technologies ability to do business with U.S. firms that soothed investor concern of an all-out tech war between Washington and Beijing.
Tesla Shares Extend Skid as Morgan Stanley Lays Out $16.4 Billion 'Bear Case'
Tesla shares are hit with yet another bearish broadside Tuesday, as analysts at Morgan Stanley weigh in on the clean-energy carmaker's prospects in China and the health of its debt-laden balance sheet.